The right team. The right model.
In a cancer-data landscape marked by big companies, technology giants, and life science companies, Taproot’s focus is on the collection of regulatory-grade data. We have spent 5 years assembling an interdisciplinary team who understands the needs of clinicians, researchers, payers, and regulators. We have built a robust technology platform and unique revenue-sharing model to make it possible.
DANE DICKSON, MD
CEO and Founder
Dr. Dickson is a medical oncologist with deep experience in clinical trial reporting, molecular medicine, and data collection.
President and Co-Founder
Rebecca Owens is a healthcare executive who has worked to advance precision medicine over the past 20 years.
RAZELLE KURZROCK, M.D.
Chief, Division of Hematology & Oncology | Director, Center for Personalized Cancer Therapy & Clinical Trials Office | Senior Deputy Director, Clinical Science | Moores Cancer Center, University of California at San Diego.
RAYMOND BERGAN, M.D.
Chief, Division of Hematology & Medical Oncology, Associate Director, Knight Cancer Institute.
JENNIFER JOHNSON, M.D., PHD
Assistant Professor, Department of Medical Oncology, Thomas Jefferson
VIVEK SUBBIAH, M.D.
Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.